DeepMed Research

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Diagnosis and Allergen Identification of Perioperative Anaphylaxis

Not yet recruiting

Conditions: Perioperative/Postoperative Complications
Anaphylaxis
Tryptase
Allergens
Skin Testing

First Posted Date: 2025-01-27

Last Posted Date: 2025-01-27

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 115

Registration Number: NCT06793163

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

Phase 4

Recruiting

Conditions: Antiphospholipid (aPL)-Positive
Thrombocytopaenia

Interventions: Drug: Sirolimus
Drug: Placebo

First Posted Date: 2024-12-09

Last Posted Date: 2025-04-30

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 84

Registration Number: NCT06722586

Locations: 🇨🇳
Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳
The 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
🇨🇳
Beijing Shijitan Hospital, Beijing, China

and more 6 locations

A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Early Phase 1

Not yet recruiting

Conditions: Multiple Myeloma and Malignant Plasma Cell Neoplasms

Interventions: Drug: 68Ga-BC1
Drug: 18F-FDG

First Posted Date: 2024-12-04

Last Posted Date: 2025-04-04

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 50

Registration Number: NCT06717113

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer

Not Applicable

Recruiting

Conditions: Prostate Cancer

First Posted Date: 2024-11-12

Last Posted Date: 2025-04-15

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 300

Registration Number: NCT06684652

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

SABR Combined with Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer

Recruiting

Conditions: Radiation Therapy
Metastatic Renal Cancer
Recurrent Renal Cell Cancer

Interventions: Radiation: Radiation therapy
Drug: Targeted and immunotherapy

First Posted Date: 2024-09-03

Last Posted Date: 2025-02-14

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 300

Registration Number: NCT06583070

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Diagnostic Test: Combination of targeted biopsy and systematic biopsy

First Posted Date: 2024-08-28

Last Posted Date: 2024-08-28

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1000

Registration Number: NCT06575361

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Evaluating the Diagnostic Efficacy of Smartwatch and Smartphone for Sleep Apnea

Recruiting

Conditions: Sleep Apnea, Obstructive

First Posted Date: 2024-08-27

Last Posted Date: 2024-10-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 295

Registration Number: NCT06573372

Locations: 🇨🇳
Cheng Zhang, Beijing, Beijing, China

Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA

Phase 4

Not yet recruiting

Conditions: Obstructive Sleep Apnea
Surgery
Dexmedetomidine
Esketamine
Postoperative Sleep Quality

Interventions: Drug: Dexmedetomidine-esketamine combination
Drug: Placebo

First Posted Date: 2024-08-22

Last Posted Date: 2024-08-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 100

Registration Number: NCT06566482

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Dexmedetomidine-esketamine Combined Nasal Administration and Emergence Delirium

Phase 4

Not yet recruiting

Conditions: Nasal Administration
Esketamine
General Anesthesia
Dexmedetomidine
Older Patients
Emergence Delirium

Interventions: Drug: Normal saline
Drug: Dexmedetomidine
Drug: Esketamine

First Posted Date: 2024-08-22

Last Posted Date: 2024-08-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 340

Registration Number: NCT06566469

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis

Not Applicable

Conditions: Renal Fibrosis
CKD

Interventions: Other: FAP-targeting PET/CT imaging will be performed on the enrolled patients.

First Posted Date: 2024-08-21

Last Posted Date: 2024-08-21

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 90

Registration Number: NCT06563765

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy